Avbryta in Baltimore: Psychiatric Care Focused on Treatment-Resistant Depression

Avbryta is a psychiatric practice in Baltimore specializing in esketamine (Spravato) administration for adults with treatment-resistant depression. Unlike traditional outpatient psychiatry, it operates as a clinical setting where patients receive intravenous or intranasal medication infusions under medical supervision, sit in a recovery area for monitoring, and return home the same day. The model fills a gap for patients who have failed two or more antidepressants at adequate doses but do not want or cannot tolerate hospitalization.

What Avbryta Actually Is

Avbryta is not a hospital, emergency room, or general psychiatry office. It is a specialized outpatient clinic licensed to administer esketamine, a fast-acting anesthetic-derived medication approved by the FDA for treatment-resistant depression and treatment-resistant major depressive disorder with suicidal ideation. The clinical model requires in-person supervision during and after infusion; patients cannot self-administer at home. Sessions typically last 2 to 2.5 hours and are spaced initially at twice weekly, then weekly intervals, with duration depending on treatment response. This setup distinguishes Avbryta from psychiatric medications taken daily at home or traditional talk therapy, and from hospital inpatient units.

Services and Pricing

Esketamine administration is the primary service. The cost per session varies widely based on insurance coverage and individual patient circumstances. Without insurance coverage, a single session typically ranges from $500 to $1,000; a full induction course (four to eight sessions over two to four weeks) can exceed $4,000 to $8,000 out-of-pocket, though many insurance plans now cover esketamine with a psychiatrist's prescription. Verify with Avbryta directly before starting whether your plan covers the medication, the infusion setting, or if prior authorization is required; coverage decisions change and differ by plan.

Comprehensive psychiatric evaluation is included before treatment begins; this appointment covers diagnosis, medication history, and screening for medical contraindications (cardiac arrhythmias, uncontrolled hypertension, active substance use). Some practices bundle follow-up psychiatric visits or medication management into the treatment package; others charge separately. Ask whether ongoing psychiatric care for comorbid conditions is included or billed separately.

How Avbryta Compares to Other Baltimore Psychiatric Options

Baltimore has several routes for treating depression. Standard outpatient psychiatrists in the city typically manage medication through office visits every four to twelve weeks without intensive monitoring; this suits stable patients but offers slower onset for treatment-resistant cases. Inpatient psychiatric units at hospitals such as Johns Hopkins Bayview, University of Maryland Medical Center, and Sinai Hospital provide crisis stabilization and intensive monitoring but require hospitalization, usually for a minimum stay of five to ten days. Transcranial magnetic stimulation (TMS) clinics in Baltimore, such as those affiliated with Johns Hopkins or Mercy Medical Center, offer another FDA-approved neurostimulation option for treatment-resistant depression administered outpatient over six weeks with five sessions weekly; TMS requires no anesthesia and involves no systemic medication, whereas esketamine has rapid onset but requires infusion supervision. Telepsychiatry services, common across Maryland, cannot deliver esketamine and suit stable medication management only. Avbryta's advantage is speed: esketamine shows response in days to weeks, whereas oral antidepressants and TMS require weeks to months. The tradeoff is the requirement for weekly clinic visits and the cost per session.

Who Avbryta Suits and Who It Does Not

Avbryta is appropriate for adults ages 18 and older with clinically diagnosed treatment-resistant depression confirmed by a psychiatrist, meaning at least two adequate antidepressant trials at therapeutic doses have failed. Patients must be medically stable enough for infusion and capable of arranged transportation home (driving is not safe immediately after esketamine); a support person accompanying the patient is encouraged but may not always be required. It suits people who want faster relief than oral medications offer and who can commit to twice-weekly clinic visits initially. Active substance use disorder, particularly ketamine abuse, is a contraindication. Severe cardiac disease, uncontrolled hypertension, psychosis, or acute suicidal crisis requiring hospitalization are barriers; in the latter case, a hospital stay typically precedes Avbryta treatment. Those seeking traditional talk therapy, medication management alone, or longer appointment intervals should explore standard psychiatric offices or telepsychiatry first.

What the First Visit Involves

The initial psychiatric evaluation includes a detailed history of past antidepressant use, dose, duration, and why each was stopped or ineffective. Vital signs are taken and baseline blood pressure is recorded; blood tests may include liver and kidney function to ensure safety. The clinician reviews medical history, current medications, and family psychiatric history. If cleared for treatment, the patient returns for the first esketamine session in a clinical space with medical equipment, where nurses insert an IV (or nasal spray is administered), vitals are monitored continuously, and a staff member remains present during and for 30 to 45 minutes after the infusion. Most patients report some dissociative symptoms (feeling detached, altered perception of space or time) during the infusion that resolve within the monitoring period. Patients are discharged to a waiting caregiver.

Hours, Parking, and Logistics

Specific hours and parking arrangements at Avbryta depend on its Baltimore location; call ahead to confirm availability, appointment wait times (currently several weeks for new patients at many esketamine clinics nationally), and parking. Some Baltimore clinics offer street parking, some have dedicated lots. Bring your insurance card and a list of all current medications and past antidepressants. Plan transportation; do not drive for at least five hours after an esketamine session. If you have a personal or family history of psychosis or substance use disorder, disclose this before booking, as it may affect eligibility.

Avbryta's place in Baltimore's mental health landscape is as a specialized option for depression that does not respond to conventional treatment, filling a role between routine psychiatry and hospital care.